Parnax Lab Ltd - Stock Valuation and Financial Performance

BSE: 506128 | NSE: | Pharmaceuticals & Drugs | Small Cap

Parnax Lab Share Price

136.45 -7.15 -4.98%
as on 12-Apr'24 16:59

DeciZen - make an informed investing decision on Parnax Lab

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Parnax Lab stock performance -

mw4me loader
P/E Ratio (SA):
65.96
Market Cap:
156.7 Cr.
52-wk low:
55
52-wk high:
167.9

Is Parnax Lab Ltd an attractive stock to invest in?

1. Is Parnax Lab Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Parnax Lab Ltd is a below average quality company.

2. Is Parnax Lab Ltd undervalued or overvalued?

The key valuation ratios of Parnax Lab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Parnax Lab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Parnax Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Parnax Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Parnax Lab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -2.7%-1.5%-1.3%1%-2.4%-0.5%-6.2%-3.3%5.1%6.1%-
Value Creation
Index
-1.2-1.1-1.1-0.9-1.2-1.0-1.4-1.2-0.6-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 17.915.97.25.35.86.57.72.47.27.58
Sales YoY Gr.--11.6%-54.4%-27%9.9%11.9%18.3%-69.1%201.7%4.5%-
Adj EPS -2.1-1.7-1.3-0.8-1.7-1-2.4-1.30.512.1
YoY Gr.-NANANANANANANANA98%-
BVPS (₹) 16.214.813.712.910.29.26.95.511.116.918.3
Adj Net
Profit
-1.8-1.5-1.1-0.7-1.4-0.9-2.1-1.10.51.12
Cash Flow from Ops. -0.3-2.11.83.70.61.72.20.5-0.4-0.3-
Debt/CF from Ops. -50.3-9.19.53.319.46.7524.2-25.5-3.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -9.3%5.2%-0.9%4.5%
Adj EPS NANANA98%
BVPS0.4%10.6%35%51.3%
Share Price 11.4% 32.2% 88.9% 134.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-12.5-11-9.4-5.9-14.5-10.4-30.4-21.55.66.911.8
Op. Profit
Mgn %
-0.7-2-4.30.161.77-19.319.121.135.1
Net Profit
Mgn %
-10.1-9.2-15.8-12.6-24.6-13.2-27-47.76.814.929.1
Debt to
Equity
1.21.51.51.11.41.41.92.40.80.1-
Working Cap
Days
322348626527461485257389148222224
Cash Conv.
Cycle
15620944235517812261881949188

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.80%

Sales growth is good in last 4 quarters at 52.17%

Sales growth has been subdued in last 3 years -0.92%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Parnax Lab Ltd.

Standalone Consolidated
TTM EPS (₹) 2.1 7.7
TTM Sales (₹ Cr.) 8.2 183
BVPS (₹.) 18.3 60.5
Reserves (₹ Cr.) 10 58
P/BV 7.46 2.25
PE 65.96 17.80
From the Market
52 Week Low / High (₹) 55.00 / 167.90
All Time Low / High (₹) 8.40 / 190.00
Market Cap (₹ Cr.) 157
Equity (₹ Cr.) 11.5
Face Value (₹) 10
Industry PE 48

Management X-Ray of Parnax Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *14.6814.6811.7811.789.419.419.419.419.419.41
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Parnax Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales181675668277
Operating Expenses 181685767366
Manufacturing Costs7421111010
Material Costs6733334133
Employee Cost 3311101011
Other Costs 2211322111
Operating Profit 0000-101012
Operating Profit Margin (%) -0.7%-2.0%-5.6%0.0%-19.1%1.7%7.0%-19.3%19.1%21.0%
Other Income 1111010000
Interest 1111111110
Depreciation 1111000000
Exceptional Items 0000000000
Profit Before Tax -1-2-1-1-2-10-112
Tax 0-100002000
Profit After Tax -1-1-1-1-2-1-2-111
PAT Margin (%) -6.8%-7.6%-14.0%-12.6%-41.4%-12.7%-26.1%-47.7%7.6%16.1%
Adjusted EPS (₹)-1.4-1.4-1.2-0.8-2.8-1.0-2.4-1.30.61.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1413121198651119
Share Capital 999999991011
Reserves 54320-1-3-418
Minority Interest0000000000
Debt161715101211111180
Long Term Debt1315137883210
Short Term Debt2223428970
Trade Payables5201111110
Others Liabilities 1110-2-10021
Total Liabilities 35332822201818162221

Fixed Assets

Gross Block1617167111111
Accumulated Depreciation89101000001
Net Fixed Assets8776111000
CWIP 0000000000
Investments 11111110101010101010
Inventories4100000111
Trade Receivables101173432021
Cash Equivalents 00000-10041
Others Assets3221555557
Total Assets 35332822201818162221

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0-224122000
PBT -1-2-1-1-2-10-112
Adjustment 1112311110
Changes in Working Capital 0-123-1111-2-2
Tax Paid 0000000000
Cash Flow From Investing Activity 0000000000
Capex 0000000000
Net Investments 0001000000
Others 0000000000
Cash Flow From Financing Activity 02-2-4-1-2-205-3
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 12-2000-6-1-1-1
Interest Paid 000-1-1-1-1-1-10
Dividend Paid 0000000000
Others 000-30-2616-2
Net Cash Flow 00000-1104-3
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-8.42-9.07-8.38-5.9-24.44-10.04-29.37-21.496.927.95
ROCE (%)-0.24-1.1-1.141.42-5.432.855.04-2.577.88.85
Asset Turnover Ratio0.530.480.240.210.270.340.430.140.370.35
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A00
Working Capital Days
Receivable Days1902324603752331841091925972
Inventory Days64594420212314563533
Payable Days287171161731361248127312383

Parnax Lab Ltd Stock News

Parnax Lab Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Parnax Lab on 12-Apr-2024 16:59 is ₹136.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2024 16:59 the market cap of Parnax Lab stood at ₹156.7.
The latest P/E ratio of Parnax Lab as of 12-Apr-2024 16:59 is 65.96.
The latest P/B ratio of Parnax Lab as of 12-Apr-2024 16:59 is 7.46.
The 52-week high of Parnax Lab is ₹167.9 and the 52-week low is ₹55.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Parnax Lab is ₹8.18 ( Cr.) .

About Parnax Lab Ltd

Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd.                                              "

In 2009, Krishna Deep Trade and Investments appointed Rasik Chaturvedi and Dilip Pimparkar as additional directors of the company with effect from February 16, 2009. Further, Rasik Chaturvedi and Dilip Pimparkar have also been inducted on the Audit Committee of the Company.

The registered office of the company is 136, Greet Western Building, Nagindas Master Road Extension, Fort Mumbai, Maharashtra-400001.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.